Direkt zum Inhalt
Merck

Chymotrypsin C mutations in chronic pancreatitis.

Journal of gastroenterology and hepatology (2011-06-03)
Jiayi Zhou, Miklós Sahin-Tóth
ZUSAMMENFASSUNG

Chronic pancreatitis is a persistent inflammatory disorder characterized by destruction of the pancreatic parenchyma, maldigestion, and chronic pain. Mutations in the chymotrypsin C (CTRC) gene encoding the digestive enzyme CTRC have been shown to increase the risk of chronic pancreatitis in European and Asian populations. Here, we review the biochemical properties and physiological functions of human CTRC, summarize the functional defects associated with CTRC mutations, and discuss mechanistic models that might explain the increased disease risk in carriers.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
αα-Chymotrypsin aus Rinderpankreas, Type II, lyophilized powder, ≥40 units/mg protein
Sigma-Aldrich
αα-Chymotrypsin, (TLCK treated to inactivate residual tryspin activity), Type VII, essentially salt-free, lyophilized powder, ≥40 units/mg protein
Sigma-Aldrich
αα-Chymotrypsin aus Rinderpankreas, Type I-S, essentially salt-free, lyophilized powder
Sigma-Aldrich
αα-Chymotrypsin aus Rinderpankreas, ≥40 units/mg protein, vial of 5 mg
Sigma-Aldrich
αα-Chymotrypsin aus Rinderpankreas, suitable for protein sequencing, salt-free, lyophilized powder
Sigma-Aldrich
α-Chymotrypsin from human pancreas, lyophilized powder
Chymotrypsin, BRP, European Pharmacopoeia (EP) Reference Standard